Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
Clinical trial NCT01837745 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01837745
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-13
- Primary completion
- 2022-04-01
- Enrollment
- 776
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.